The modulatory effect of the tumor microenvironment is evident in CLL with the functional success of BTKi inhibitors and when comparing peripheral blood CLL cells to active CLL in lymphoid tissue.55, 56. Here, IBTK is linked to B-cell chronic lymphocytic leukemia.